Furosemide as Supportive Therapy for COVID-19 Respiratory Failure
Clinical trial NCT04588792 · TERMINATED
Trial details
- NCT number
- NCT04588792
- Sponsor
- Dr. John Muscedere
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-16
- Primary completion
- 2023-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.